The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 9721868)

Published in Cancer Res on August 15, 1998

Authors

J A Taylor1, D M Umbach, E Stephens, T Castranio, D Paulson, C Robertson, J L Mohler, D A Bell

Author Affiliations

1: Epidemiology Branch, Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA. taylor@niehs.nih.gov

Articles citing this

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet (2005) 5.01

N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene (2006) 2.03

GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis (2010) 1.35

Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis (2005) 1.29

The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect (1999) 1.20

The role of genetic polymorphisms in environmental health. Environ Health Perspect (2003) 1.09

Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis (2008) 1.05

Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer (1999) 0.96

Review of studies on metabolic genes and cancer in populations of African descent. Genet Med (2010) 0.96

Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect (1999) 0.95

Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1. Drug Metab Rev (2008) 0.92

Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut (2000) 0.90

Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer (2006) 0.90

GENERAL THEORY FOR INTERACTIONS IN SUFFICIENT CAUSE MODELS WITH DICHOTOMOUS EXPOSURES. Ann Stat (2012) 0.86

N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. Br J Cancer (2000) 0.86

N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population. J Oncol (2012) 0.82

Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions. Birth Defects Res A Clin Mol Teratol (2011) 0.79

The case-only independence assumption: associations between genetic polymorphisms and smoking among controls in two population-based studies. Int J Mol Epidemiol Genet (2012) 0.79

Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland. Biochem Genet (2010) 0.77

Challenges identifying genetic determinants of pediatric cancers--the childhood leukemia experience. Fam Cancer (2006) 0.77

Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct. Carcinogenesis (2011) 0.76

NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis. Int J Clin Exp Med (2015) 0.75

International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics. Arch Public Health (2016) 0.75

Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism. BMC Cancer (2017) 0.75

Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility. Medicine (Baltimore) (2015) 0.75

N-Acetyltransferase polymorphism and human cancer risk. Environ Health Prev Med (2000) 0.75

Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis. Oncotarget (2017) 0.75

Articles by these authors

Differences in hospital asthma management. Lancet (1988) 5.86

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol (2002) 4.32

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res (2001) 4.12

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet (1998) 3.83

Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59

A study of proactive ethics consultation for critically and terminally ill patients with extended lengths of stay. Crit Care Med (1998) 3.57

Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology (1991) 3.38

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res (2001) 3.37

Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19

When will nondifferential misclassification of an exposure preserve the direction of a trend? Am J Epidemiol (1994) 3.13

The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02

Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst (1999) 2.90

Management of asthma in hospital: a prospective audit. Br Med J (Clin Res Ed) (1988) 2.77

Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst (1993) 2.76

Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. American Heart Association. Circulation (1997) 2.68

Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67

Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis (1998) 2.65

Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax (1993) 2.62

Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) (2012) 2.52

Using pooled exposure assessment to improve efficiency in case-control studies. Biometrics (1999) 2.51

The Dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development. J Dent Res (2003) 2.48

Finding a benchmark for monitoring hospital cleanliness. J Hosp Infect (2010) 2.40

The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int (2003) 2.32

Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens (2003) 2.25

Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhanced conventional spin-echo MR? AJNR Am J Neuroradiol (1996) 2.24

XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res (1999) 2.21

Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet (1989) 2.20

A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology (1991) 2.18

XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis (2000) 2.16

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology (2001) 2.10

Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology (1995) 2.00

A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Ann Surg (1996) 2.00

Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res (1996) 1.96

p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A (1993) 1.93

Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res (1998) 1.92

An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res (1997) 1.92

Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol (1997) 1.90

Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol (2011) 1.90

Choosing a retrospective design to assess joint genetic and environmental contributions to risk. Am J Epidemiol (2000) 1.89

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res (1993) 1.89

INTERMAP: the dietary data--process and quality control. J Hum Hypertens (2003) 1.88

Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill (2011) 1.84

Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet (1996) 1.81

International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79

Term infants with hypoxic-ischemic encephalopathy: outcome at 3.5 years. Dev Med Child Neurol (1985) 1.69

Variation within global cigarette brands in tar, nicotine, and certain nitrosamines: analytic study. Tob Control (2000) 1.65

Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst (1998) 1.64

Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev (1996) 1.64

Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum (1980) 1.62

Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res (2001) 1.61

Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61

Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab (1994) 1.60

The effect of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry (1985) 1.59

Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (1998) 1.58

Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors. Cancer (2001) 1.58

Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.57

Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int (2004) 1.56

Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? Thorax (1994) 1.56

Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur Respir J (1999) 1.56

A hybrid design for studying genetic influences on risk of diseases with onset early in life. Am J Hum Genet (2005) 1.56

Cleanliness audit of clinical surfaces and equipment: who cleans what? J Hosp Infect (2011) 1.56

Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55

Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci U S A (1989) 1.55

Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women. J Clin Oncol (1999) 1.53

The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol (1991) 1.52

Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord (2000) 1.51

Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6-7 year old children: ISAAC Phase Three. Allergol Immunopathol (Madr) (2011) 1.51

The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol (1998) 1.50

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia. Urology (2001) 1.49

Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol (2000) 1.48

Colorectal cancer follow-up: perspectives for future studies. Eur J Surg Oncol (2000) 1.47

Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer (2000) 1.46

Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46

Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess (2010) 1.45

Transitional cell metaplasia of the uterine cervix and vagina: an underrecognized lesion that may be confused with high-grade dysplasia. A report of 59 cases. Am J Surg Pathol (1997) 1.44

Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill (2015) 1.44

The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer (1993) 1.43

Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.43

Prognostic significance of DNA content in epithelial ovarian cancer. Gynecol Oncol (1994) 1.43

Wide distribution of granulophysin epitopes in granules of human tissues. Lab Invest (1993) 1.43

Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43

Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia. Gynecol Oncol (1993) 1.42

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum (1988) 1.40

Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin. J Clin Invest (1984) 1.40

GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.40

The 1998 European Resuscitation Council guidelines for adult advanced life support: A statement from the Working Group on Advanced Life Support, and approved by the executive committee. Resuscitation (1998) 1.39

Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet (2000) 1.39

The influence of humidity, sunlight, and temperature on the daytime decay of polyaromatic hydrocarbons on atmospheric soot particles. Environ Sci Technol (1988) 1.39

Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol (2003) 1.38

Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res (1994) 1.38

Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol (2000) 1.35

Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.35

Higher blood pressure in middle-aged American adults with less education-role of multiple dietary factors: the INTERMAP study. J Hum Hypertens (2003) 1.34

Elemental content of airway surface liquid from infants with cystic fibrosis. Am J Respir Crit Care Med (1998) 1.34

Mealtime difficulties in a home for the aged: not just dysphagia. Dysphagia (1997) 1.34

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med (1999) 1.32